Recombinate Articles
Merck Serono debuts easypod injection device
5 February 2007
Gardasil could slash cervical cancer 78%
29 January 2007
Headlines 25 years ago this week....
22 January 2007
Shire's Elaprase gets EU OK for Hunter synd
22 January 2007
Shire's Elaprase gets EU OK for Hunter synd
22 January 2007
2M-euro FP6 funding from Crete Univ/novosom AG
15 January 2007
MA for GTC Bio's ATryn goes to Leo
8 January 2007
Crucell unit gets EU grant for malaria vaccine
22 December 2006
CBER delays Ph II trial of VaxGen anthrax vacc
22 December 2006
Daily NovoSeven cuts bleed frequency 45%
22 December 2006
Roche licenses Halozyme's Enhanze in deal worth upto $581M
11 December 2006
ThromboGenics and Bharat sign THR licensing deal
11 December 2006
Roche to use Halozyme' Enhanze technology
11 December 2006
Novo Nordisk milestone for Neose
4 December 2006
MorphoSys/Burnham Inst sign Ab R&D deal
4 December 2006
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
DOR BioPharma reports progress on RiVax vaccine formulation
20 November 2006
Biovitrum in manufacturing deal with Resistentia
13 November 2006
Bentley initiates Ph II trial of insulin nose spray
13 November 2006
USA's CDC adds Merck & Co's Gardasil to its VFC contract
6 November 2006
Mixed results for Novo Nordisk in 3rd-qtr 2006
6 November 2006
Serono's 3rd-qtr 2006 sales rise 8.4% on Rebif
30 October 2006
US FDA clears NovoNordisk
23 October 2006
Less price flexibility, more innovation: the market dynamics of targeted therapeutics
16 October 2006
Lek to construct 6.7M euro biopharma site
9 October 2006
MorphoSys to develop Abs for USAMRIID
2 October 2006
Good anemia control in CKD for Shire's Dynepo
25 September 2006
Bioton aims at 20% of Russian insulin market
25 September 2006
OctoPlus launches its Euronext IPO
25 September 2006
CepTor in deal to buy Ferring's r-h CuZnSOD
25 September 2006
13 new drugs added to Japan's NHI list
18 September 2006
Ipsen's 1st-half 2006 profit falls 6.6%
18 September 2006
Sweden's Biovitrum launches IPO
11 September 2006
Sanofi MSD's Gardasil could cross-protect
11 September 2006
ITC will not review initial verdict in Roche case
11 September 2006
Altus agrees ALTU-238 manufacturing deal with Althea
4 September 2006
Laureate and Lpath agree Sphingomab production deal
28 August 2006
Fresenius Kabi licenses HESylation platform to Sandoz
28 August 2006
MedImmune files IND for MT103 with US FDA
28 August 2006
Serono reports positive data for r-hGH in HARS
28 August 2006
Novo milestone for Neose Technologies
14 August 2006
Novo Nordisk's 1st-half 2006 sales rise 20%
7 August 2006
Sandoz and Momenta to collaborate on generics R&D
31 July 2006
Pharming NV submits rhC1INH to EMEA
31 July 2006
Amgen's 2nd-qtr 2006 sales up 14% to $3.6B
31 July 2006
Bayer debuts free US patient trial of Kognate
24 July 2006
Novartis passes 50% threshold in NeuTec buy
17 July 2006
ITC judge rules peg-EPO covered by exemption
17 July 2006
Crucell and DSM reveal Invitrogen as first partner
17 July 2006
CHMP Update on current activities
10 July 2006
Strong early data for Helix's L-DOS47
3 July 2006
Menopur more effective than rFSH in IVF
26 June 2006
Orphan designation for Pharming's rhC1INH from FDA
19 June 2006
US FDA approves Merck & Co's Gardasil: First cervical cancer vacc, potential blockbuster
19 June 2006
Innogenetics' HCV tech granted US/EU patents
19 June 2006
GSK's sees strong efficacy across wide age group
12 June 2006
India
12 June 2006
Gardasil gets FDA nod for cervical cancer
29 May 2006
Strong PKC profile for BAY 79-4980
29 May 2006
Cambridge Labs' Valtropin cleared in EU
15 May 2006
Novo Nordisk's 1st-qtr 2006 sales up 23%
15 May 2006
Selexis signs licensing deal with Diosynth
8 May 2006
Bayer AG sees record-breaking 1st qtr with EBIT up 8.2% to $1.56 billion on strong health care sales
8 May 2006
OctoPlus' Locteron sees good Ph I data
1 May 2006
Bayer Yakuhin sees 2005 sales rise 4%
1 May 2006
Eli Lilly profit up 6% in 1st-qtr 2006
1 May 2006
EC approves Sandoz' Omnitrope
24 April 2006
Amgen files with ITC to stop Roche's peg-EPO imports
17 April 2006
Teva increases stake in Chinese biotech group
10 April 2006
Purivax tech can speed flu vacc development
10 April 2006
Blue Heron Biotech gets Ph II SBIR grant
20 March 2006
EMEA guidelines on similar biologicals
20 March 2006
US FDA guidance to expedite flu vaccs
20 March 2006
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
